These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 23215841)
1. Assessing the prospect of donepezil in improving cognitive impairment in patients with schizophrenia. Thakurathi N; Vincenzi B; Henderson DC Expert Opin Investig Drugs; 2013 Feb; 22(2):259-65. PubMed ID: 23215841 [TBL] [Abstract][Full Text] [Related]
2. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. Lee BJ; Lee JG; Kim YH J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979 [TBL] [Abstract][Full Text] [Related]
3. Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Nahas Z; George MS; Horner MD; Markowitz JS; Li X; Lorberbaum JP; Owens SD; McGurk S; DeVane L; Risch SC Neurocase; 2003 Jun; 9(3):274-82. PubMed ID: 12925933 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease. Prvulovic D; Schneider B Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):1039-50. PubMed ID: 24785550 [TBL] [Abstract][Full Text] [Related]
5. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study. Fagerlund B; Søholm B; Fink-Jensen A; Lublin H; Glenthøj BY Clin Neuropharmacol; 2007; 30(1):3-12. PubMed ID: 17272964 [TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study. Pérez M; Tůma I; Pytela O; Kadlecová E; Zemanová M; Lenderová Z Eur Psychiatry; 2006 Dec; 21(8):548-50. PubMed ID: 16797936 [TBL] [Abstract][Full Text] [Related]
7. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC Cogn Neuropsychiatry; 2007 Sep; 12(5):412-21. PubMed ID: 17690999 [TBL] [Abstract][Full Text] [Related]
8. Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression. McDermott CL; Gray SL Ann Pharmacother; 2012 Apr; 46(4):599-605. PubMed ID: 22414791 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of low-dose donepezil in schizophrenia. Erickson SK; Schwarzkopf SB; Palumbo D; Badgley-Fleeman J; Smirnow AM; Light GA Clin Neuropharmacol; 2005; 28(4):179-84. PubMed ID: 16062097 [TBL] [Abstract][Full Text] [Related]
10. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report. Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508 [TBL] [Abstract][Full Text] [Related]
11. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment? Stiles MM; Martin S; Persons RK J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040 [No Abstract] [Full Text] [Related]
18. Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia. Karamihalev S; Prickaerts J; van Goethem NP Behav Brain Res; 2014 Oct; 272():248-51. PubMed ID: 25036424 [TBL] [Abstract][Full Text] [Related]
19. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia. Akhondzadeh S; Gerami M; Noroozian M; Karamghadiri N; Ghoreishi A; Abbasi SH; Rezazadeh SA Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1810-5. PubMed ID: 18727948 [TBL] [Abstract][Full Text] [Related]
20. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis. Harry RD; Zakzanis KK Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]